NCT03495427 PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores Status RECRUITING Phase PHASE2/PHASE3
NCT03494803 Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC Status WITHDRAWN Phase N/A
NCT03493997 Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC) Status COMPLETED Phase PHASE2
NCT03493945 Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) Status COMPLETED Phase PHASE1/PHASE2
NCT03489057 Efficacy of a Couple-Focused mHealth Symptom Self-management Program Status COMPLETED Phase NA
NCT03488810 Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer Status WITHDRAWN Phase PHASE3
NCT03488706 Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level Status UNKNOWN Phase N/A
NCT03486886 PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility Status COMPLETED Phase NA
NCT03482089 Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion Status UNKNOWN Phase NA
NCT03478904 Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer Status TERMINATED Phase PHASE1
NCT03477591 Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions Status COMPLETED Phase NA
NCT03471650 Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03465579 Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. Status TERMINATED Phase NA
NCT03465345 Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Status WITHDRAWN Phase PHASE1
NCT03459820 Prostate Cancer Patient Management With 18F-DCFPyL PET/CT Status ENROLLING_BY_INVITATION Phase PHASE2/PHASE3
NCT03459755 Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors Status WITHDRAWN Phase NA
NCT03458247 Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer Status COMPLETED Phase PHASE2